Celanese Presents EVA Polymer Solutions for Drug Delivery Systems at CPhI Worldwide
Tue, October 6 2015
Innovative pharmaceutical solutions made possible with Celanese EVA polymers
“EVA has been used for years in drug delivery systems,” said
Celanese material experts will discuss these topics and more at a Pharma Insight Briefing & Reception:
- Why use EVA in Drug Development and Controlled Release
- Current Application Areas and Uses of EVA
- Next Generation Innovations for EVA
- Celanese Support of Conventional and Novel Uses of EVA
Celanese Pharma Insight Briefing & Reception
Date/Time: |
|
|
Location: |
|
|
Presenters: |
Dr. |
|
Topic: |
Innovative Uses of Ethylene Vinyl Acetate (EVA) in Drug Delivery Systems: Novel and Conventional |
|
For more information about Celanese’s controlled release pharmaceutical EVA polymer, VitalDose EVA, visit www.vitaldose.com.
About Celanese
All registered trademarks are owned by
Forward-Looking Statements
This release may contain “forward-looking statements,” which include
information concerning the company’s plans, objectives, goals,
strategies, future revenues or performance, capital expenditures,
financing needs and other information that is not historical
information. When used in this release, the words “outlook,” “forecast,”
“estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,”
“believes,” and variations of such words or similar expressions are
intended to identify forward-looking statements. All forward-looking
statements are based upon current expectations and beliefs and various
assumptions. There can be no assurance that the company or any of its
customers will realize these benefits or that these expectations will
prove correct. There are a number of risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements contained in this release. Numerous factors, many of which
are beyond the company’s control, could cause actual results to differ
materially from those expressed as forward-looking statements. Other
risk factors include those that are discussed in the company’s filings
with the
View source version on businesswire.com: http://www.businesswire.com/news/home/20151006005129/en/
Celanese
Investor Relations
jon.puckett@celanese.com
or
Media
Relations – Global
william.jacobsen@celanese.com
or
Media
Relations Asia (
lan.zhang@celanese.com
or
Media
Relations Europe (
j.kurth@celanese.com
Source: